Miriam Bach is a seasoned professional in the pharmaceutical industry with extensive experience in cardiovascular studies and medical affairs. Currently serving as VP and Head of Studies & Pipeline at Bayer since May 2022, Miriam previously held the position of VP and Head of Cardiovascular Studies & Pipeline at Bayer Pharmaceuticals from March 2021 to April 2022. Prior roles at Bayer also included Senior Medical Affairs Scientist and Scientist in Global Medical Affairs related to thrombosis. Before joining Bayer, Miriam worked at Boehringer Ingelheim from May 2011 to December 2014 as a Medical Advisor and Medical Science Liaison in the cardiovascular domain.
This person is not in the org chart
This person is not in any teams
This person is not in any offices